We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$612M
AUM Growth
+$115M
Cap. Flow
+$88.3M
Cap. Flow %
14.44%
Top 10 Hldgs %
8.98%
Holding
532
New
97
Increased
238
Reduced
88
Closed
80

Sector Composition

Rank Sector Weight
1 Financials 20.46%
2 Real Estate 16.88%
3 Energy 14.34%
4 Healthcare 10.85%
5 Materials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
501
PayPal
PYPL
$49.5B
-389
Closed -$40K
RDY icon
502
Dr. Reddy's Laboratories
RDY
$9.8B
$0 ﹤0.01%
50
-120
-71% -$948
RTX icon
503
RTX Corp
RTX
$294B
-462
Closed -$40K
SBUX icon
504
Starbucks
SBUX
$120B
-448
Closed -$40K
SNAP icon
505
Snap
SNAP
$7.5B
-694
Closed -$11K
STT icon
506
State Street
STT
$50.5B
-256
Closed -$15K
STX icon
507
Seagate
STX
$180B
-296
Closed -$16K
TGT icon
508
Target
TGT
$63.4B
-245
Closed -$26K
TRV icon
509
Travelers Companies
TRV
$81.4B
-166
Closed -$25K
TWLO icon
510
Twilio
TWLO
$29.2B
-81
Closed -$9K
ULTA icon
511
Ulta Beauty
ULTA
$20.5B
-43
Closed -$11K
VFC icon
512
VF Corp
VFC
$6.74B
-118
Closed -$11K
VZ icon
513
Verizon
VZ
$197B
-1,026
Closed -$62K
WDC icon
514
Western Digital
WDC
$167B
-361
Closed -$16K
ZBRA icon
515
Zebra Technologies
ZBRA
$12.6B
-70
Closed -$14K
ZTS icon
516
Zoetis
ZTS
$32.4B
-151
Closed -$19K
GRTS
517
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-25,698
Closed -$222K
CBAY
518
DELISTED
Cymabay Therapeutics
CBAY
-40,232
Closed -$206K
SPLK
519
DELISTED
Splunk Inc
SPLK
-155
Closed -$18K
PHAS
520
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
-21,738
Closed -$91K
CTXS
521
DELISTED
Citrix Systems Inc
CTXS
-125
Closed -$12K
ETFC
522
DELISTED
E*Trade Financial Corporation
ETFC
-430
Closed -$19K
THOR
523
DELISTED
Synthorx, Inc. Common Stock
THOR
-19,810
Closed -$322K
WCG
524
DELISTED
Wellcare Health Plans, Inc.
WCG
-52
Closed -$13K
ARQL
525
DELISTED
Arqule Inc
ARQL
-30,806
Closed -$221K

Similar funds

Virtus ETF Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Virtus ETF Advisers held 532 positions worth $612M, up 23% from $496M the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Virtus ETF Advisers deployed $88.3M of net new capital in Q4 2019, opening 97 new positions and adding to 238 existing holdings. Its largest new stake was Odonate Therapeutics, Inc. Common Stock: 14,229 shares worth $462K.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 24% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was Oxford Square Capital, an estimated $2.73M trimmed.

  • Virtus ETF Advisers's largest Q4 2019 buy was Odonate Therapeutics, Inc. Common Stock: 14,229 shares worth $462K.
  • Virtus ETF Advisers added most to Telecom Argentina in Q4 2019, an estimated $2.03M increase.
  • Virtus ETF Advisers's biggest Q4 2019 reduction was Oxford Square Capital, cutting an estimated $2.73M.
  • Virtus ETF Advisers fully exited Medicines Co in Q4 2019, selling an estimated $982K.
  • Virtus ETF Advisers's ten largest holdings make up 9% of its $612M portfolio in Q4 2019.
  • Virtus ETF Advisers opened 97 new positions and closed 80 in Q4 2019.
  • Virtus ETF Advisers's portfolio value rose 23% quarter-over-quarter to $612M.

Based on Virtus ETF Advisers's 13F filing for Q4 2019, filed 13 Feb 2020.